Magnetic resonance-guided biopsy of the prostate: Feasibility, technique, and clinical applications

Topics in Magnetic Resonance Imaging

Volumn 19, Issue 6, 2008, Pages 291-295

  Yakar, Derya ^a   Hambrock, Thomas ^a   Hoeks, Caroline ^a   Barentsz, Jelle O ^a   Fütterer, Jurgen J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

MR guided biopsy; MRI; Prostate cancer; Prostate cancer localization

Indexed keywords

CIPROFLOXACIN; GADOTERATE MEGLUMINE; CONTRAST MEDIUM; MEGLUMINE; ORGANOMETALLIC COMPOUND;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CASE REPORT; CLINICAL PRACTICE; DATA ANALYSIS; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; HUMAN; MALE; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY; TUMOR LOCALIZATION; BIOPSY; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; INSTRUMENTATION; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; METHODOLOGY; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

AGED; BIOPSY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 68049142174     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e3181aacdb0     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Tewari A, Divine G, Chang P, et al. Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy - a propensity scoring approach. J Urol. 2007;177:911-915.
3. Rabbani F, Stroumbakis N, Kava BR, et al. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol. 1998; 159:1247-1250.
4. Chun FK, Steuber T, Erbersdobler A, et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol. 2006;49:820-826.
5. Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol. 2000;174: 623-627.
6. Roehrborn CG, Pickens GJ, Sanders JS. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. Urology. 1996;47:347-352.
7. Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001;166:86-91.
8. Prando A, Kurhanewicz J, Borges AP, et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology. 2005;236:903-910.
9. Yuen JS, Thng CH, Tan PH, et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol. 2004;171: 1482-1486.
10. Anastasiadis AG, Lichy MP, Nagele U, et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol. 2006;50:738-748.
11. Beyersdorff D, Winkel A, Hamm B, et al. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology. 2005;234:576-581.
12. Engelhard K, Hollenbach HP, Kiefer B, et al. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol. 2006;16:1237-1243.
13. Kim CK, Park BK, Lee HM, et al. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol. 2007;42:842-847.
14. Fütterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology. 2006;241:449-458.
15. Fütterer JJ, Engelbrecht MR, Huisman HJ, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology. 2005;237:541-549.
16. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 2003;229: 248-254.
17. Xu J, Humphrey PA, Kibel AS, et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med. 2009;61:842-850.
18. Hambrock T, Fütterer JJ, Huisman HJ, et al. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol. 2008;43:686-694.
19. Singh AK, Kruecker J, Xu S, et al. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int. 2008;101:841-845.